Initiated Mkt Perform X

TLRY Tilray

Bernstein

$3.90

Downgrades Hold Sell X

TLRY Tilray

The Benchmark Company

$3

Initiated Underweight X

TLRY Tilray

Barclays

$10

Downgrades Overweight Neutral X

TLRY Tilray

Cantor Fitzgerald

$18 $11.80

Downgrades Sec Outperform Neutral X

TLRY Tilray

CIBC

$25

Upgrades Neutral Overweight X

TLRY Tilray

Cantor Fitzgerald

$30.25 $22

Resumed Outperform X

TLRY Tilray

Cowen

$20

Resumed Buy X

TLRY Tilray

Jefferies

$23

Initiated Hold X

TLRY Tilray

Canaccord Genuity

$17

Resumed Buy X

TLRY Tilray

BofA Securities

$23

Downgrades Overweight Neutral X

TLRY Tilray

Piper Sandler

$15 $26

Downgrades Buy Hold X

TLRY Tilray

The Benchmark Company

Reiterated Buy X

TLRY Tilray

The Benchmark Company

$200 $80

Initiated Neutral X

TLRY Tilray

Ladenburg Thalmann

Initiated Overweight X

TLRY Tilray

Consumer Edge Research

Initiated Hold X

TLRY Tilray

Stifel

Initiated Perform X

TLRY Tilray

Oppenheimer

Upgrades Underperform Mkt Perform X

TLRY Tilray

BMO Capital Markets

Initiated Neutral X

TLRY Tilray

Alliance Global Partners

$50

Upgrades Underperform Hold X

TLRY Tilray

Jefferies

$61 $57

Initiated Underperform X

TLRY Tilray

Jefferies

Initiated Neutral X

TLRY Tilray

Seaport Global Securities

Initiated Overweight X

TLRY Tilray

Piper Jaffray

Initiated Buy X

TLRY Tilray

The Benchmark Company

$200

Resumed Neutral X

TLRY Tilray

ROTH Capital

Downgrades Outperform Mkt Perform X

TLRY Tilray

Northland Capital

Initiated Buy X

TLRY Tilray

ROTH Capital

$35

TLRY  Tilray Inc

Tilray Inc. is engaged in sale and development of medical cannabis. Geographically, the company derives majority of its revenue from Canada. The product categories of the company include dried cannabis which include whole flower and ground flower,and cannabis extract which include full spectrum and purified oil drops and capsules.